The FDA announced on November 30, 2012, that West-Ward Pharmaceutical Corp. voluntarily recalled Lisinopril and Hydrochlorothiazide Tablets due to the presence of foreign stainless steel particulates. The agency classified the recall as Class II.
How to tell if you have it
- Brand: West-Ward Pharmaceutical
- Product: Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg
- NDC 0143-1264-01 (100-count bottles)
- NDC 0143-1264-10 (1000-count bottles)
- Lot codes: 69392A, 69393A, 69394A, 69395A, 69396A, 69397A (Exp 09/15); 69495A, 69496A, 69497A, 69498A, 69524A, 69525A (Exp 10/15)
The hazard
The recall addresses reports of gray smudges identified as minute stainless steel particulates found in the recalled tablets. The FDA stated that these foreign substances pose a potential health risk.
Context
GovInfoNow's records show West-Ward Pharmaceutical Corp. has had 23 other recalls on record since April 13, 2012. Other recent recalls of similar products include Merck Noxafil Powdermix Recall (December 12, 2025) and Sunny Pharmtech Cyclophosphamide Injection Recall (July 17, 2026).